GeneDx Holdings Corp. — Director's Dealing 2021

Oct 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sema4 Holdings Corp. (SMFR)
CIK: 0001818331
Period of Report: 2021-10-01

Reporting Person: Prentice Anthony (Chief Product Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-01	Employee Stock Option (Right to Buy)	$7.62	A	42033	Acquired	2031-09-30	Class A Common Stock (42033)	Direct
2021-10-01	Restricted Stock Unit	$	A	63049	Acquired		Class A Common Stock (63049)	Direct

Footnotes

F1: 6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

F2: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.